Saturday, 31 October 2026European Markets

ING GROEP N.V., SPAREBANKEN VEST, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Financial Services Sector.

Loading stream...

(vianews) - ing groep n.v. (inga.as) is among this list of stock assets with the highest dividend rate and return on equity on the financial services sector.

financial asset price forward dividend yield return on equity
ing groep n.v. (inga.as) €15.53 7.21% 8.24%
sparebanken vest (sveg.ol) kr126.34 5.93% 17.74%
bourse direct (bsd.pa) €5.10 3.22% 22.35%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. ing groep n.v. (inga.as)

7.21% forward dividend yield and 8.24% return on equity

ing groep n.v. provides various banking products and services in the netherlands, belgium, germany, rest of europe, and internationally. it operates through five segments: retail netherlands, retail belgium, retail germany, retail other, and wholesale banking. the company accepts current and savings accounts. it also offers business lending products; sme loans; consumer lending products, such as residential mortgage loans and other consumer lending loans; and mortgages. in addition, the company provides working capital solutions; debt and equity market solutions; various loans; payments; and cash management, trade and corporate finance, and treasury services, as well as savings, investment, insurance, and digital banking services. it serves individual customers, corporate clients, and financial institutions. ing groep n.v. was founded in 1762 and is headquartered in amsterdam, the netherlands.

earnings per share

as for profitability, ing groep n.v. has a trailing twelve months eps of €2.08.

pe ratio

ing groep n.v. has a trailing twelve months price to earnings ratio of 7.47. meaning, the purchaser of the share is investing €7.47 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.24%.

dividend yield

as stated by morningstar, inc., the next dividend payment is on apr 24, 2024, the estimated forward annual dividend rate is 1.11 and the estimated forward annual dividend yield is 7.21%.

moving average

ing groep n.v.'s worth is under its 50-day moving average of €15.82 and way above its 200-day moving average of €13.70.

more news about ing groep n.v..

2. sparebanken vest (sveg.ol)

5.93% forward dividend yield and 17.74% return on equity

sparebanken vest, a financial services company, provides banking and financing services in the counties of vestland and rogaland, norway. the company operates through corporate market, retail market, bulder bank, treasury, and estate agency activities segments. it is also involved in home mortgage activities. sparebanken vest was founded in 1823 and is headquartered in bergen, norway.

earnings per share

as for profitability, sparebanken vest has a trailing twelve months eps of kr14.01.

pe ratio

sparebanken vest has a trailing twelve months price to earnings ratio of 9.02. meaning, the purchaser of the share is investing kr9.02 for every norwegian krone of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.74%.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, sparebanken vest's stock is considered to be oversold (<=20).

sales growth

sparebanken vest's sales growth is 19.8% for the ongoing quarter and 18.1% for the next.

more news about sparebanken vest.

3. bourse direct (bsd.pa)

3.22% forward dividend yield and 22.35% return on equity

bourse direct sa provides internet stock brokerage services in france. it offers a platform of services, tools, and financial products, including french and foreign equities, derivatives, trackers, warrants, certificates, turbos, mutual funds, ucits, and cfds, as well as tax exemption, retirement, real estate, and life insurance products through the boursedirect.fr, capitol.fr, tradebox.fr, abssysteme.fr, wargny.com, and mesactions.com sites. the company was founded in 1996 and is headquartered in paris, france. bourse direct sa is a subsidiary of e-viel sa. bourse direct et bourse discount sa provides french and foreign equities, derivatives, trackers, warrants, certificates, turbos, ucits, cfds, tax exemption products, real estate products, and direct horizon stock exchange life insurance contracts. the company was was incorporated in 1996 and is based in paris, france.

earnings per share

as for profitability, bourse direct has a trailing twelve months eps of €0.3.

pe ratio

bourse direct has a trailing twelve months price to earnings ratio of 17. meaning, the purchaser of the share is investing €17 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 22.35%.

revenue growth

year-on-year quarterly revenue growth grew by 48.9%, now sitting on 66.44m for the twelve trailing months.

dividend yield

as claimed by morningstar, inc., the next dividend payment is on may 22, 2024, the estimated forward annual dividend rate is 0.16 and the estimated forward annual dividend yield is 3.22%.

more news about bourse direct.

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com